advertisement
11.14 Investigational drugs; pharmacological experiments (147)
Showing records 1 to 25
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments60621 Effect of AR-13324 on Episcleral Venous Pressure in Dutch Belted Rabbits
Kiel JW
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 146-151
60295 Novel potential treatment modalities for ocular hypertension: focus on Angiotensin and bradykinin system axes
Sharif NA
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 131-145
60768 Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action
Bozdag M
Bio-organic and Medicinal Chemistry 2015; 23: 2368-2376
60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
White AJ
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201
60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Stein JD
PLoS ONE 2015; 10: e0123682
60098 Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery
Ferreira JD
Current Eye Research 2014; 0: 1-7
60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Nagai N
Experimental Eye Research 2015; 132: 115-123
60162 Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes
Wang RF
Journal of Glaucoma 2015; 24: 51-54
60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Weinreb RN
British Journal of Ophthalmology 2015; 99: 738-745
60210 Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits
Iomdina EN
Front Biosci 2015; 20: 892-901
60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Loma P
Experimental Eye Research 2015; 134: 141-147
60538 A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Raber S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 189-197
60275 Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
Harrison BA
ACS Medicinal Chemistry Letters 2015; 6: 84-88
60786 Options for prolonging the hypotensive effect of trabeculectomy
Vestnik Oftalmologii 2015; 131: 75-78, 80-81
60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Sakamoto K
European Journal of Pharmacology 2015; 756: 52-58
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Tanihara H
Acta Ophthalmologica 2015; 93: e254-e260
60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Chen YS
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193
60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Parsons CG
Neuropharmacology 2015; 92: 158-169
60296 Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients
Pescosolido N
Ophthalmic and Physiological Optics 2015; 35: 201-205
60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Lindsey JD
Neurobiology of Aging 2015; 0:
60436 Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma
Pirhan D
Current Eye Research 2015; 0: 1-11
60429 Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models
Wang X
Investigative Ophthalmology and Visual Science 2015; 56: 1357-1366
60570 BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas
Valiente-Soriano FJ
Investigative Ophthalmology and Visual Science 2015; 56: 1924-1936
60664 Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma
Yanagisawa M
Cell Death and Disease 2015; 6: e1693
60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Green CR
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193